Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy

Aiden Haghikia, Edith Podewski, Elena Libhaber, +12

Basic Research in Cardiology

HypertensionHeart FailureGerman CohortCardiovascular PharmacologyPpcm Patients +19

MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells

Céline Sabatel, Ludovic Malvaux, Nicolas Bovy, +8

PLoS ONE

miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization

Karmele Valencia, Diego Luis-Ravelo, Nicolas Bovy, +11

Molecular Oncology

Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer

Nicolas Bovy, Benoît Blomme, Pierre Frères, +12

Oncotarget

Circulating microRNA-based screening tool for breast cancer

Pierre Frères, Stéphane Wenric, Meriem Boukerroucha, +13

Oncotarget

Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR‐34a and miR‐122 Expression

Pierre Frères, Claire Josse, Nicolas Bovy, +4

Journal of Cellular Physiology

Tumor BiologyBreast OncologyOncologyMedicineImmunology +12

Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial

Hanisah Sharif, Iesha Singh, Lubna Kouser, +19

Journal of Allergy and Clinical Immunology

Clinical ImmunologyAllergyAutoimmune DiseaseImmunodeficienciesImmunology +9

MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells

Sébastien P. Tabruyn, Sylvain Hansen, Luisa Ojeda‐Fernández, +7

Angiogenesis

AngiogenesisEndothelial CellsHereditary Hemorrhagic TelangiectasiaEndothelial DysfunctionPathology +5

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes

Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie, +14

BMC Medicine

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers

Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie, +8

BMC Medicine